U.S. health inspectors are still struggling to address a massive backlog of pharmaceutical plants that went uninspected ...
The production limit for lisdexamfetamine was increased by 6,236 kilograms, which includes 1,558 kg to address increased ...
Nearly five years after COVID-19, a new analysis by The Associated Press shows that U.S. regulators are struggling to address ...
The leadership change comes after psychedelic drugmaker Lykos lost its bid for FDA approval.
The FDA has been backlogged in drug factory inspections since before the COVID-19 pandemic, a new report found.
The FDA says the latest vaccine formulae "closely targets currently circulating variants" to give better protection against ...
A common food dye can turn the skin of living mice transparent, but we don't yet know if it'll work in humans.
Under FDA's own guidelines, drug factories that haven't been inspected in five or more years are considered a significant ...
The firms that are overdue for safety and quality inspections represent about 42% of the 4,700 plants that are currently ...
Simcere Pharmaceuticals Group Ltd. (2096.HK) announced that Sanbexin Sublingual Tablets (Edaravone and Dexborneol sublingual tablets), an innovative drug for stroke, has been granted the Breakthrough ...
Federal regulators responsible for the safety of the U.S. drug supply are still struggling to get back to where they were in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results